Northwestern Mutual Wealth Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
NAMA
Northwestern Mutual Wealth Management's PACB Position: Q2 2026 in Review
Northwestern Mutual Wealth Management reduced its Pacific Biosciences (PACB) stake by 96% in Q2 2026, selling an estimated $387 and leaving 10 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #4050.
Northwestern Mutual Wealth Management first reported a position in PACB in Q2 2015 and has held it in 20 quarters since. The position peaked at $263K in Q4 2015. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.
- Northwestern Mutual Wealth Management held 10 shares of Pacific Biosciences worth $17 as of Q2 2026.
- Northwestern Mutual Wealth Management sold 266 Pacific Biosciences shares in Q2 2026, an estimated $387.
- Pacific Biosciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4050 holding.
- Northwestern Mutual Wealth Management first reported a position in Pacific Biosciences in Q2 2015 and has held it in 20 quarters since.
- Northwestern Mutual Wealth Management's Pacific Biosciences position peaked at $263K in Q4 2015.
- 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.